Triple Gate Capital

Triple Gate Capital is a specialized investment firm focused on the healthcare and life sciences sectors. The firm provides strategic capital to both public and private companies, leveraging deep clinical and scientific expertise to identify high-impact medical innovations. Founded by Dr. Thomas J. Lynch, Jr., a renowned oncologist and former Chief Scientific Officer at Bristol Myers Squibb, the firm focuses on bridging the gap between breakthrough science and commercial success. Triple Gate Capital invests across the healthcare spectrum, including therapeutics, diagnostics, and digital health, with a particular emphasis on oncology and precision medicine. The firm's investment approach is characterized by a rigorous evaluation of clinical data and market potential to support the development of transformative therapies.